Business Practice

Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).

Brexit is a serious challenge for UK businesses trading with the EU.

Pharma companies have been raising awareness for years, but patients continue to buy counterfeit medicines online.

Drug pricing concerns, facility expansions and regulatory changes... What’s new for pharma in business?

Single-use biotech process equipment is already making use of technology to automate processes and the level of complexity is increasing.

Sitting Down With… Charles Gore, Executive Director, Medicines Patent Pool (MPP), Geneva, Switzerland.

Rethinking our approach to the use of energy and resources could help transform our relationship with the environment.

We only have one planet. We must play a responsible role when it comes to its care.

Can’t offer an “affordable” price? Then say goodbye to market exclusivity.

Joe Biden apparently dared say there were “great drug companies out there – except for a couple of opioid outfits.”